Foot and mouth disease: The future of vaccine banks

OIE Revue Scientifique et Technique

Volumn 21, Issue 3, 2002, Pages 601-612

  Forman, A J ^a   Garland, A J M ^b  

^a Forman and Friend Pty Ltd   (Australia)

^b NONE   (United Kingdom)

Author keywords

Emergencies; Foot and mouth disease; Foot and mouth disease vaccine; Vaccination; Vaccine banks

Indexed keywords

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 0036944034     PISSN: 02531933     EISSN: None     Source Type: Journal    
DOI: 10.20506/rst.21.3.1359     Document Type: Review

References (40)

1. Adamowicz P.H., Legrand B., Guerche J. & Prunet P. (1974). - Un nouveau procédé de concentration et purification de virus. Application au virus de fièvre aphteuse produit sur cellules BHK 21 pour l'obtention de vaccins hautement purifiés. Bull. Off. int. Epiz., 81, 1125-1150.
2. Amadori M. (1997). - Strategy for emergency vaccination and consequences on trade and disease control methods. In Report of a Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 23-27 September, Poiana-Brasov. EUFMD, Rome, Appendix 20. 114-119.
3. Anon. (1969). - Report of the Committee of Inquiry on Foot and Mouth Disease, 1968, Part 1. Her Majesty's Stationery Office, London, Cmnd 3999, 1-133.
4. Anon. (1989). - Report from the Commission to the Council on a study carried out by the Commission on policies currently applied by Member States in the control of Foot-and-Mouth Disease. Commission of European Communities (CEC), Brussels, 1-24.
5. Anon. (1994). - Virus strains for vaccine banks. In Report of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 15-22 September, Vienna. EUFMD, Rome, Item 8, 8-9.
6. Anon. (1997). - FMD situation in Europe; Balkans, Greece, Turkey and other regions. In Report of the 32nd Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 2-4 April, Rome. EUFMD, Rome, Appendix 1, 29-45.
7. 1 Manisa foot and mouth disease vaccine for the UK by the International Vaccine Bank (IVB), 22 March-4 April 2001. In Report of a Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 12-15 September, Island of Moen. EUFMD, Rome, Appendix 8, 60-63.
8. Barnett P.V. & Statham R.J. (1995). - Long-term stability and potency of antigen concentrates held by the international vaccine bank. In Report of the 31st Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 5-7 April, Rome. EUFMD, Rome, Appendix 9, 60-65.
9. Barnett P.V., Samuel A.R. & Statham R.J. (2001). - The suitability of the 'emergency' foot and mouth disease antigens held by the International Vaccine Bank within a global context. Vaccine, 19 (15-19), 2107-2117.
10. Barnett P.V. & Statham R.J. (2001). - Stratified and cryogenically stored (SACS) vaccines, a new concept in emergency foot-and-mouth disease vaccine formulation and storage. Vaccine, 20 (16), 2060-2064.
11. Barteling S., Swann H., Anemat D.A.J., Tuyn C. & Vreeswijk J. (1996). - Foot-and mouth disease vaccines based on antigens in the European vaccine bank are very potent. In Report of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 2-6 September, Ma'ale Hachamisha. EUFMD, Rome, Appendix 12, 68-70.
12. Callis J. (1994). - Vaccine banks: present status and future developments. In 62nd General Session of the Office International des Epizooties (OIE), 16-20 May, Paris. OIE, Paris, Report 62/SG 10, 1-6.
13. Cox S.J., Dani P., Salt J.S. amp; Barnett P.V. (1998). - Effect of emergency vaccines on local virus replication and virus persistence in sheep using two different adjuvant formulations. In Report of a Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 14-18 September, Aldershot. EUFMD, Rome, Appendix 17, 129-143.
14. Cox S.J., Barnett P.V., Dani P. & Salt J.S. (1999). - Emergency vaccination of sheep against foot and mouth disease: protection against disease and reduction in contact transmission. Vaccine, 17, 1855-1868.
15. De Diego M., Brocchi E., Mackay D. & De Simone F. (1997). - The use of the non-structural polyprotein 3ABC of foot and mouth disease virus as a diagnostic antigen to differentiate infected from vaccinated cattle. Arch. Virol., 14, 2021-2033.
16. De Klercq K. (2001). - Report of the activities of the Research Group of the Standing Technical Committee for the period 1999-2000. In Report of the 34th Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 21-23 March, Rome. EUFMD, Rome, Appendix 10, 103-107.
17. Doel T.R. (1996). - Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccine. Rev. sci. tech. Off. int. Epiz., 15 (3), 883-911.
18. Doel T.R. (2001). - Repeated administration of maximum payload emergency vaccines made from inactivated purified antigen concentrates do not induce significant titres of antibodies against non-structural proteins of foot-and-mouth disease virus. In Report of a Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 12-15 September, Island of Moen. EUFMD, Rome, Appendix 18, 88-92.
19. Doel T.R. & Pullen L. (1990). - International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them. Vaccine, 8 (5), 473-478.
20. Doel T.R., Williams L. & Barnett P.V. (1994). - Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine, 12 (7), 592-600.
21. Donaldson A.I. & Kitching R.P. (1989). - Transmission of foot and mouth disease by vaccinated cattle following natural challenge. Res. vet. Sci., 46, 9-14.
22. Donaldson A.I. & Have P. (1996). - Criteria to consider and operational requirements for implementing emergency (ring) vaccination. In Report of a Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 2-6 September, Ma'ale Hachamisha. EUFMD, Rome, Appendix 29, 201-207.
23. Donaldson A.I., Alexandersen S., Sorensen J.H. & Mikkelsen T. (2001). - The relative risks of the uncontrollable (airborne) spread of foot and mouth disease by different species. Vet. Rec., 148, 602-604.
24. Garland A.J.M. (1997). - The availability of vaccines for emergency vaccination in Europe. In Report of the 32nd Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 2-4 April, Rome. EUFMD, Rome, Appendix 8, 89-111.
25. Garland A.J.M. (1999). - Vital elements for the successful control of foot and mouth disease by vaccination. Vaccine, 17, 1760-1766.
26. Horst S. (1999). - Risk and economic consequences of exotic animal disease outbreaks: computer simulation to help set priorities in policy making. In Report of a Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 29 September-1 October, Maisons-Alfort. EUFMD, Rome, Appendix 1, 13-16.
27. Keeling M.J., Woolhouse M.E., Shaw D.J., Matthews M., Chase-Topping M., Haydon D.T., Cornell S.J., Kappey J., Wilesmith J. & Grenfell B.T. (2001). - Dynamics of the 2001 UK foot and mouth disease outbreak: stochastic dispersal in a heterogeneous landscape. Science, 294, 813-817.
28. Leforban Y. (1995). - Availability of vaccines for emergency vaccination in Europe. In Report of the 31st Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 5-7 April, Rome. EUFMD, Rome, Appendix 9, 60-65.
29. Mackay D., Forsyth M.A., Davies P.R., Berlinzani A., Belsham G.J., Flint M. & Ryan M.D. (1998). - Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine, 16 (5), 446-459.
30. Murray P.K. (1992). - A review of foot and mouth disease international vaccine banks. In Proc. National Symposium on Foot and Mouth Disease (M.J. Nunn & P.M. Thornber, eds), 8-10 September, Canberra. Australian Government Publication Service, Canberra, 115-123.
31. Office International des Epizooties (OIE) (2001). - Foot and mouth disease, Chapter 2.1.1. In International animal health code: mammals, birds and bees, 10th Ed. OIE, Paris, 63-75.
32. Office International des Epizooties (OIE) (2001). - Foot and mouth disease, Part 2, Section 2.1., OIE List A diseases, Chapter 2.1.1. In Manual of standards for diagnostic tests and vaccines, 4th Ed., 2000. OIE, Paris, 77-92.
33. Rweyemamu M.M., Black L., Boge A., Thorne A.C. & Terry G. (1984). - The relationship between the 140S antigen dose in aqueous foot and mouth disease vaccine and the serum neutralisation response of cattle. J. biol. Standard., 12, 111-120.
34. Ryan J. (2001). - The availability of foot-and-mouth disease vaccine for emergency vaccination in Europe. In Report of the 34th Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 21-23 March, Rome. EUFMD, Rome, Appendix 12, 117-127.
35. Salt J.S. (1998). - Persistent infections with foot and mouth disease virus. Topics trop. Virol., 1, 77-128.
36. Salt J.S., Wiliams L. & Barnett P.V. (1996). - Efficacy studies in pigs with two novel oil-adjuvanted emergency vaccines. In Report of a Session of the Research Group of the Standing Technical Committee and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 2-6 September, Ma'ale Hachamisha. EUFMD, Rome, Appendix 23, 162-169.
37. Salt J.S., Barnett P.V., Dani P. & Williams L. (1998). - Emergency vaccination of pigs against foot and mouth disease: protection against disease and reduction in contact transmission. Vaccine, 16, 746-754.
38. Sanson R.L., Morris R.S. & Stern M.W. (1999). - EpiMAN-FMD: a decision support system for managing epidemics of vesicular disease. Rev. sci. tech. Off. int. Epiz., 18 (3), 593-605.
39. Sobrino F., Saiz M., Jimenez-Clavero M.A., Nunez J.I., Rosas M.F., Baranowski E. & Ley V. (2001). - Foot and mouth disease virus: a long known virus, but a current threat. Vet. Res., 32 (1), 1-30.
40. Zakharov V.M., Baibikov T.Z., Rakhmanov A.M. & Dudnikov A.I. (1995). - Foot and mouth disease control strategies in the Russian Federation and ex-USSR countries. In Report of the Meeting of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 20-22 September, Vladimir. EUFMD, Rome, Appendix 13, 81-83.